UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 86

Sortiert nach

Itaconate confers tolerance to late NLRP3 inflammasome activation

Cell reports (Cambridge), 2021-03, Vol.34 (10), p.108756-108756, Article 108756

2021

Volltextzugriff (PDF)

Fabrication of full-color GaN-based light-emitting diodes on nearly lattice-matched flexible metal foils

Scientific reports, 2017-05, Vol.7 (1), p.2112-5, Article 2112

2017

Volltextzugriff (PDF)

Characterization of GaN films grown on hafnium foils by pulsed sputtering deposition

Physica status solidi. A, Applications and materials science, 2017-10, Vol.214 (10), p.n/a

2017

Volltextzugriff (PDF)

Antibacterial Effect of Naringin‐containing Soft Contact Lens

Bulletin of the Korean Chemical Society, 2021, 42(10), , pp.1345-1350

2021

Volltextzugriff (PDF)

Restoration of Traditional Korean Nuruk and Analysis of the Brewing Characteristics

Journal of microbiology and biotechnology, 2017-05, Vol.27 (5), p.896-908

2017

Volltextzugriff (PDF)

IDH1 Splicing Alterations in Patients with AML and Their Relationship to Blood 2HG Levels

Blood, 2014-12, Vol.124 (21), p.1060-1060

2014

Volltextzugriff (PDF)

Metabolic Profiling Using Stable Isotope Tracing Reveals Distinct Patterns of Glucose Utilization by Physiologically Activated CD8+ T Cells

Immunity (Cambridge, Mass.), 2019-11, Vol.51 (5), p.856-870.e5

2019

Volltextzugriff (PDF)

Comparative evaluation of itaconate and its derivatives reveals divergent inflammasome and type I interferon regulation in macrophages

Nature metabolism, 2020-07, Vol.2 (7), p.594

2020

Volltextzugriff (PDF)

Combinatorially Responsive, Polarity-Indicative, Charge Transfer Dye-Based Polymer Gels for Odor Visualization in VOC Sensor Array

Macromolecules, 2009-02, Vol.42 (4), p.902-904

2009

Volltextzugriff (PDF)

Decreased activity and stability of pyruvate kinase in sickle cell disease: a novel target for mitapivat therapy

Blood, 2021-05, Vol.137 (21), p.2997-3001

2021

Volltextzugriff (PDF)

Evaluation of safety and tolerability of durvalumab (D) and tremelimumab (T) in combination with first-line chemotherapy in patients (pts) with esophageal squamous-cell carcinoma (ESCC)

Journal of clinical oncology, 2019-02, Vol.37 (4_suppl), p.146-146

2019

Volltextzugriff (PDF)

Governing through creativity: Discursive formation and neoliberal subjectivity in Korean firms

Organization (London, England), 2019-03, Vol.26 (2), p.175-198

2019

Volltextzugriff (PDF)

Comparative evaluation of metabolic, electrophilic, and immunologic effects of itaconate and its ester derivatives on macrophage activation

The Journal of immunology (1950), 2020-05, Vol.204 (1_Supplement), p.73-73.1

2020

Volltextzugriff (PDF)

A machine learning based prediction model of anti-PD-1 therapy response using noninvasive clinical information and blood markers of lung cancer patients

Journal of clinical oncology, 2019-05, Vol.37 (15_suppl), p.e14138-e14138

2019

Volltextzugriff (PDF)

Preclinical Drug Metabolism, Pharmacokinetic, and Pharmacodynamic Profiles of Ivosidenib, an Inhibitor of Mutant Isocitrate Dehydrogenase 1 for Treatment of Isocitrate Dehydrogenase 1-Mutant Malignancies

Drug metabolism and disposition, 2021-10, Vol.49 (10), p.870-881

2021

Volltextzugriff (PDF)

A phase II trial of preoperative chemoradiotherapy and pembrolizumab for locally advanced esophageal squamous cell carcinoma (ESCC)

Journal of clinical oncology, 2019-05, Vol.37 (15_suppl), p.4027-4027

2019

Volltextzugriff (PDF)

Itaconate confers tolerance to late NLRP3 inflammasome activation

The Journal of immunology (1950), 2021-05, Vol.206 (1_Supplement), p.15-15.11

2021

Volltextzugriff (PDF)

Isocitrate Dehydrogenase 1 (IDH1) Mutation in Breast Adenocarcinoma Is Associated With Elevated Levels of Serum and Urine 2‐Hydroxyglutarate

The oncologist (Dayton, Ohio), 2014-06, Vol.19 (6), p.602-607

2014

Volltextzugriff (PDF)

Lazertinib, a 3 rd generation EGFR-TKI, in patients with EGFR-TKI resistant NSCLC: Updated results of phase I/II Study

Journal of clinical oncology, 2019-05, Vol.37 (15_suppl), p.9037-9037

2019

Volltextzugriff (PDF)

Defining the immunologic phenotypes and their prognostic impacts on head and neck squamous cell cancer (HNSCC)

Journal of clinical oncology, 2016-05, Vol.34 (15_suppl), p.6055-6055

2016

Volltextzugriff (PDF)

Genomic profiling of lung adenocarcinoma patients reveals potential therapeutic targets when standard molecular testing is negative

Journal of clinical oncology, 2016-05, Vol.34 (15_suppl), p.e20575-e20575

2016

Volltextzugriff (PDF)

Brigatinib (BRG) versus crizotinib (CRZ) in Asian versus non-Asian patients (pts) in the phase III ALTA-1L trial

Journal of clinical oncology, 2019-05, Vol.37 (15_suppl), p.9026-9026

2019

Volltextzugriff (PDF)

1 – 25 von 86

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(81)
Mit Volltextzugriff
(83)

Publikationsform

Artikel
(85)
Tagungsberichte
(1)

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(41)
Life Sciences & Biomedicine
(20)
Physical Sciences
(15)
Humans
(11)
Technology
(10)
Female
(8)
Animals
(7)
Chemistry
(7)
Science & Technology - Other Topics
(7)
Materials Science
(5)
Materials Science, Multidisciplinary
(5)
Mice
(5)
Middle Aged
(5)
Biochemistry & Molecular Biology
(4)
Cell Proliferation
(4)
Localization
(4)
Male
(4)
Multidisciplinary Sciences
(4)
Optics
(4)
Polymer Science
(4)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Itaconate confers tolerance to late NLRP3 inflammasome activation

Discovery of AG-120 (Ivosidenib): A First-in-Class Mutant IDH1 Inhibitor for the Treatment of IDH1 Mutant Cancers

Fabrication of full-color GaN-based light-emitting diodes on nearly lattice-matched flexible metal foils

Circulating Oncometabolite 2-Hydroxyglutarate Is a Potential Surrogate Biomarker in Patients with Isocitrate Dehydrogenase-Mutant Intrahepatic Cholangiocarcinoma

Characterization of GaN films grown on hafnium foils by pulsed sputtering deposition

Antibacterial Effect of Naringin‐containing Soft Contact Lens

Restoration of Traditional Korean Nuruk and Analysis of the Brewing Characteristics

IDH1 Splicing Alterations in Patients with AML and Their Relationship to Blood 2HG Levels

Metabolic Profiling Using Stable Isotope Tracing Reveals Distinct Patterns of Glucose Utilization by Physiologically Activated CD8+ T Cells

Electrophilic properties of itaconate and derivatives regulate the IκBζ-ATF3 inflammatory axis

Comparative evaluation of itaconate and its derivatives reveals divergent inflammasome and type I interferon regulation in macrophages

Combinatorially Responsive, Polarity-Indicative, Charge Transfer Dye-Based Polymer Gels for Odor Visualization in VOC Sensor Array

Decreased activity and stability of pyruvate kinase in sickle cell disease: a novel target for mitapivat therapy

Evaluation of safety and tolerability of durvalumab (D) and tremelimumab (T) in combination with first-line chemotherapy in patients (pts) with esophageal squamous-cell carcinoma (ESCC)

Governing through creativity: Discursive formation and neoliberal subjectivity in Korean firms

Comparative evaluation of metabolic, electrophilic, and immunologic effects of itaconate and its ester derivatives on macrophage activation

A machine learning based prediction model of anti-PD-1 therapy response using noninvasive clinical information and blood markers of lung cancer patients

Preclinical Drug Metabolism, Pharmacokinetic, and Pharmacodynamic Profiles of Ivosidenib, an Inhibitor of Mutant Isocitrate Dehydrogenase 1 for Treatment of Isocitrate Dehydrogenase 1-Mutant Malignancies

A phase II trial of preoperative chemoradiotherapy and pembrolizumab for locally advanced esophageal squamous cell carcinoma (ESCC)

Itaconate confers tolerance to late NLRP3 inflammasome activation

Isocitrate Dehydrogenase 1 (IDH1) Mutation in Breast Adenocarcinoma Is Associated With Elevated Levels of Serum and Urine 2‐Hydroxyglutarate

Lazertinib, a 3 rd generation EGFR-TKI, in patients with EGFR-TKI resistant NSCLC: Updated results of phase I/II Study

Defining the immunologic phenotypes and their prognostic impacts on head and neck squamous cell cancer (HNSCC)

Genomic profiling of lung adenocarcinoma patients reveals potential therapeutic targets when standard molecular testing is negative

Brigatinib (BRG) versus crizotinib (CRZ) in Asian versus non-Asian patients (pts) in the phase III ALTA-1L trial

Suchergebnisse filtern